Correlation Between ChemoMetec and Conferize

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ChemoMetec and Conferize at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec and Conferize into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and Conferize AS, you can compare the effects of market volatilities on ChemoMetec and Conferize and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec with a short position of Conferize. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec and Conferize.

Diversification Opportunities for ChemoMetec and Conferize

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ChemoMetec and Conferize is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and Conferize AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conferize AS and ChemoMetec is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with Conferize. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conferize AS has no effect on the direction of ChemoMetec i.e., ChemoMetec and Conferize go up and down completely randomly.

Pair Corralation between ChemoMetec and Conferize

Assuming the 90 days trading horizon ChemoMetec AS is expected to generate 0.43 times more return on investment than Conferize. However, ChemoMetec AS is 2.34 times less risky than Conferize. It trades about 0.04 of its potential returns per unit of risk. Conferize AS is currently generating about -0.01 per unit of risk. If you would invest  39,800  in ChemoMetec AS on December 2, 2024 and sell it today you would earn a total of  18,300  from holding ChemoMetec AS or generate 45.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ChemoMetec AS  vs.  Conferize AS

 Performance 
       Timeline  
ChemoMetec AS 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, ChemoMetec exhibited solid returns over the last few months and may actually be approaching a breakup point.
Conferize AS 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Conferize AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Conferize sustained solid returns over the last few months and may actually be approaching a breakup point.

ChemoMetec and Conferize Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ChemoMetec and Conferize

The main advantage of trading using opposite ChemoMetec and Conferize positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec position performs unexpectedly, Conferize can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conferize will offset losses from the drop in Conferize's long position.
The idea behind ChemoMetec AS and Conferize AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets